Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects

Neuroendocrinology

Volumn 88, Issue 2, 2008, Pages 103-110

  Giltay, Erik J ^a   Bunck, Mathijs C ^b   Gooren, Louis J ^b   Zitman, Frans G ^a   Diamant, Michaela ^b   Teerlink, Tom ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amino acid; Sex hormones; Testosterone; Transsexuals

Indexed keywords

AMINO ACID; CYPROTERONE ACETATE; ETHINYLESTRADIOL; NEUROTRANSMITTER; NITRIC OXIDE; PHENYLALANINE; SEX HORMONE; TRYPTOPHAN; TYROSINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; MALE; MALE TO FEMALE TRANSSEXUAL; NEUROTRANSMISSION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AMINO ACIDS, AROMATIC; CYPROTERONE ACETATE; ETHINYL ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MODELS, BIOLOGICAL; NEUROTRANSMITTER AGENTS; PHENYLALANINE; SUBSTRATE SPECIFICITY; SYNAPTIC TRANSMISSION; TESTOSTERONE; TRANSSEXUALISM; TRYPTOPHAN; TYROSINE;

EID: 50649091356     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135710     Document Type: Article

References (34)

1. Dunlop BW, Nemeroff CB: The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007;64:327-337.
2. Fernstrom JD, Fernstrom MH: Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr 2007;137:1539S-1547S.
3. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Blier P, Diksic M: Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 1997;94:5308-5313.
4. Coppen A, Ecclesto E, Craft I, Bye P: Total and free plasma-tryptophan concentration and oral contraception. Lancet 1973;2:1498.
5. Maes M, Claes M, Schotte C, Delbeke L, Jacquemyn Y, Verkerk R, Demeester I, Scharpe S: Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy. J Psychosom Res 1992;36:191-197.
6. Cowen PJ, Parrybillings M, Newsholme EA: Decreased plasma tryptophan levels in major depression. J Affect Disord 1989;16:27-31.
7. 11C]methyl-L-tryptophan, an index of serotonin synthesis, is lower in females than males. Neuroimage 2006;33:815-824.
8. Moller SE, Maach-Møller B, Olesen M, Fjalland B: Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle. Eur J Clin Pharmacol 1996;50:179-184.
9. Moller SE, MaachMoller B, Olesen M, Madsen B, Madsen P, Fjalland B: Tyrosine metabolism in users of oral-contraceptives. Life Sci 1995;56:687-695.
10. Fadel PJ, Wang Z, Watanabe H, Arbique D, Vongpatanasin W, Thomas GD: Augmented sympathetic vasoconstriction in exercising forearms of postmenopausal women is reversed by oestrogen therapy. J Physiol 2004;561:893-901.
11. Kaur G, Janik J, Isaacson LG, Callahan P: Estrogen regulation of neurotrophin expression in sympathetic neurons and vascular targets. Brain Res 2007;1139:6-14.
12. Giltay EJ, Kho KH, Blansjaar BA, Verbeek MM, Geurtz PBH, Geleijnse JM, Gooren LJG: The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects. J Endocrinol 2005;187:109-116.
13. Giltay EJ, Elbers JM, Gooren LJ, Emeis JJ, Kooistra T, Asscheman H, Stehouwer CD: Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol 1998;18:1716-1722.
14. Teerlink T, Vanleeuwen PAM, Houdijk A: Plasma amino-acids determined by liquid-chromatography within 17 minutes. Clin Chem 1994;40:245-249.
15. Pardridge WM: Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem Res 1998;23:635-644.
16. Smith QR: Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr 2000;130:1016S-1022S.
17. Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB: Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 1988;47:7-14.
18. Newhouse PA, Dumas J, Hancur-Bucci C, Naylor M, Sites CK, Benkelfat C, Young SN: Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women. Neuropsychopharmacology 2008;33:1514-1527.
19. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB: Sex and depression in the National Comorbidity Survey. I. Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85-96.
20. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK: Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293-299.
21. Gater R, Tansella M, Korten A, Tiemens BG, Mavreas VG, Olatawura MO: Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings - Report from the World Health Organization collaborative study on Psychological Problems in General Health Care. Arch Gen Psychiatry 1998;55:405-413.
22. McTavish SFB, McPherson MH, Harmer CJ, Clark L, Sharp T, Goodwin GM, Cowen PJ: Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 2001;179:356-360.
23. Salter M, Knowles RG, Pogson CI: How does displacement of albumin-bound tryptophan cause sustained increases in the free tryptophan concentration in plasma and 5-hydroxytryptamine synthesis in brain? Biochem J 1989;262:365-368.
24. Pope HG Jr, Cohane GH, Kanayama G, Siegel AJ, Hudson JI: Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160:105-111.
25. Delgado PL, Miller HL, Salomon RM, Licinio J, Krystal JH, Moreno FA, Heninger GR, Charney DS: Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 1999;46:212-220.
26. Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, Bain EE, Luckenbaugh DA, Herscovitch P, Charney DS, Drevets WC: Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 2004;61:765-773.
27. Seidman SN: Testosterone deficiency and mood in aging men: pathogenic and therapeutic interactions. World J Biol Psychiatry 2003;4:14-20.
28. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS: Risk of the 'androgen deprivation syndrome' in men receiving androgen deprivation for prostate cancer. Arch Intern Med 2006;166:465-471.
29. Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR: Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 2005;62:154-162.
30. Resnick SM, Maki PM, Rapp SR, Espeland MA, Brunner R, Coker LH, Granek IA, Hogan P, Ockene JK, Shumaker SA: Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 2006;91:1802-1810.
31. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA: Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy - Results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA 2002;287:591-597.
32. Arbogast LA, Hyde JF: Estradiol attenuates the forskolin-induced increase in hypothalamic tyrosine hydroxylase activity. Neuroendocrinology 2000;71:219-227.
33. Dluzen DE, Park JH, Kim K: Modulation of olfactory bulb tyrosine hydroxylase and catecholamine transporter mRNA by estrogen. Brain Res Mol Brain Res 2002;108:121-128.
34. Freeman ME, Kanyicska B, Lerant A, Nagy G: Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000;80:1523-1631.